Cite
Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome.
MLA
Luke, Rachel A., et al. “Elevated Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels in Smith-Lemli-Opitz Syndrome.” Molecular Genetics & Metabolism, vol. 143, no. 1/2, Sept. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ymgme.2024.108570.
APA
Luke, R. A., Cawley, N. X., Rahhal, S., Selvaraman, A., Thurm, A., Wassif, C. A., & Porter, F. D. (2024). Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome. Molecular Genetics & Metabolism, 143(1/2), N.PAG. https://doi.org/10.1016/j.ymgme.2024.108570
Chicago
Luke, Rachel A., Niamh X. Cawley, Samar Rahhal, Aishwarya Selvaraman, Audrey Thurm, Christopher A. Wassif, and Forbes D. Porter. 2024. “Elevated Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels in Smith-Lemli-Opitz Syndrome.” Molecular Genetics & Metabolism 143 (1/2): N.PAG. doi:10.1016/j.ymgme.2024.108570.